BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3971397)

  • 1. Possible interactions between warfarin and antineoplastic drugs.
    Seifter EJ; Brooks BJ; Urba WJ
    Cancer Treat Rep; 1985 Feb; 69(2):244-5. PubMed ID: 3971397
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities.
    Malacarne P; Maestri A
    Recenti Prog Med; 1996 Mar; 87(3):135. PubMed ID: 8650435
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin, etoposide, and vindesine interactions.
    Ward K; Bitran JD
    Cancer Treat Rep; 1984 May; 68(5):817-8. PubMed ID: 6539172
    [No Abstract]   [Full Text] [Related]  

  • 4. Deep venous thrombosis with localized skin necrosis.
    Brennan M; Morgan HJ; George A
    J Tenn Med Assoc; 1986 Apr; 79(4):210. PubMed ID: 3713169
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy.
    Bissett D; Kaye SB; Baxter G; Moss J
    Clin Oncol (R Coll Radiol); 1996; 8(4):247-9. PubMed ID: 8871003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of bleeding tendency due to warfarin in a patient treated with chemotherapy by S-1].
    Yasui Y; Nishiguchi T; Yamamoto A; Fujii C; Fujino M; Tsuge M; Ohno M; Azuma J; Matsumura T; Ohsato H; Anami S; Furukawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1367-70. PubMed ID: 18701850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arterial thrombosis in a patient after chemotherapy (BEP protocol) for extra-gonadal dysgerminoma].
    Schmidt J; Zenut M; De Marquilly F; Maciejewski C; Plagne R; Lavarenne J
    Therapie; 1995; 50(5):476-8. PubMed ID: 8571294
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline.
    Jankel CA; McMillan JA; Martin BC
    Am J Hosp Pharm; 1994 Mar; 51(5):661-6. PubMed ID: 8203385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of prothrombin time with the use of indomethacin and warfarin.
    Chan TY
    Br J Clin Pract; 1997; 51(3):177-8. PubMed ID: 9293062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
    Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
    Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone-cyclophosphamide-fluorouracil-combination chemotherapy in metastatic breast cancer. 3-Year-follow-up.
    Büyükünal E; Derman U; Serdengeçti S; Berkarda B
    J Chemother; 1989 Jul; 1(4 Suppl):1201-2. PubMed ID: 16312833
    [No Abstract]   [Full Text] [Related]  

  • 16. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy.
    Lee CK; Lynch J
    Intern Med J; 2007 Apr; 37(4):281-2. PubMed ID: 17388876
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium.
    Krstenansky PM; Jones WN; Garewal HS
    Clin Pharm; 1987 Oct; 6(10):804-6. PubMed ID: 3505843
    [No Abstract]   [Full Text] [Related]  

  • 18. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive problems after chemotherapy for breast cancer.
    Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.